NCT04037384

Brief Summary

The aim of the trial is to investigate the possibilities of improving visual impairments with eye training exercises (eye-yoga) in a total of 40 patients with glaucoma who have not previously been treated within a similar training program. 20 patients will be instructed how to do eye yoga to be performed dails for 4 weeks (max 30 min/day). As a control group of 20 patients will be instructed to read for 30 min/day for 4 weeks. The following outcome measures will be investigated: High Resolution Perimetry, Humphrey Perimetry, Visual Acuity Test, Contrast Sensitivity Test, Microsaccades measurements, Intraocular Pressure Measurement, Electroencephalogram (EEG), Blood Pressure and Pulse Measurement and Dynamic Vessel Analysis (DVA - the blood supply in the eye (especially vascular dysregulation) . Furthermore, factors that could influence response variability and the effectiveness of treatment will be analysed: (i) the role of mental stress (or stress resilience) and (ii) the influence of personality traits and quality of life. The study is intended to further validate this home training program (eye yoga) for the treatment of visual impairment in glaucoma.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2019

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 30, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

February 9, 2021

Status Verified

February 1, 2021

Enrollment Period

3.4 years

First QC Date

July 3, 2019

Last Update Submit

February 4, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual field size determined by perimetry measurements

    Changes of the visual field's size, evaluated by static perimetry and high resolution perimetry measurements

    4 weeks

  • Microsaccade measurements

    Changes in the deviation of eye movements when visual targets are followed, using a computerized test

    4 weeks

Secondary Outcomes (2)

  • Blood circulation in the eye

    4 weeks

  • EEG connectivities

    4 weeks

Study Arms (2)

Eye Yoga group

ACTIVE COMPARATOR

Eye yoga exercises

Behavioral: Passive Reading

Reading Group

PLACEBO COMPARATOR

Passive reading

Behavioral: Eye yoga

Interventions

Eye yogaBEHAVIORAL

Eye yoga exercises at home given by a trained instructor

Reading Group
Passive ReadingBEHAVIORAL

Passive reading at home

Eye Yoga group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinical diagnosis of glaucoma
  • residual vision
  • the duration of the disease must be at least 6 months old
  • the visual field defect must be stable

You may not qualify if:

  • autoimmune diseases in the acute stage
  • neurological and mental diseases
  • diabetic retinopathy
  • addictions
  • hypertension (maximum 160/100 mmHg)
  • retinitis pigmentosa-
  • pathological nystagmus
  • non-distant tumors or recurrent tumors
  • photosensitivity
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Inst. of Medical Psychology, Univ. of Magdeburg

Magdeburg, 39120, Germany

RECRUITING

Institute of Medical Psychology

Magdeburg, 39120, Germany

RECRUITING

Related Publications (3)

  • Dada T, Mittal D, Mohanty K, Faiq MA, Bhat MA, Yadav RK, Sihota R, Sidhu T, Velpandian T, Kalaivani M, Pandey RM, Gao Y, Sabel BA, Dada R. Mindfulness Meditation Reduces Intraocular Pressure, Lowers Stress Biomarkers and Modulates Gene Expression in Glaucoma: A Randomized Controlled Trial. J Glaucoma. 2018 Dec;27(12):1061-1067. doi: 10.1097/IJG.0000000000001088.

    PMID: 30256277BACKGROUND
  • Sabel BA, Flammer J, Merabet LB. Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review. Restor Neurol Neurosci. 2018;36(6):767-791. doi: 10.3233/RNN-180880.

    PMID: 30412515BACKGROUND
  • Zhou W, Sabel BA. Vascular dysregulation in glaucoma: retinal vasoconstriction and normal neurovascular coupling in altitudinal visual field defects. EPMA J. 2023 Feb 16;14(1):87-99. doi: 10.1007/s13167-023-00316-6. eCollection 2023 Mar.

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Bernhard A Sabel, PhD

    University of Magdeburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bernhard A Sabel, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Institute, Professor

Study Record Dates

First Submitted

July 3, 2019

First Posted

July 30, 2019

Study Start

August 1, 2019

Primary Completion

December 31, 2022

Study Completion

August 1, 2023

Last Updated

February 9, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will share

The results will be available without restriction

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
After the results are published, unlimited duration
Access Criteria
Contact to the principal investigator

Locations